A new report by Leaps by Bayer, Boston Consulting Group (BCG), and Ipsos UK provides a deeper understanding of why people respond differently to emerging technologies and what innovators can do to build trust and legitimacy. Based on in-depth interviews in China, Germany, and the United States, the report explores the drivers of public optimism, caution, and resistance toward AI in healthcare, cell and gene therapies (CGT), new genomic techniques (NGTs) in agriculture, and cultivated meat. The
2026 Copyright © News-Matic.com. All Rights Reserved
